The discrepancy in results could be due to different subsets of patients in the present study (anti-MOG positive anti-AQP4 negative NMOSD patients) and those of Cobo-Calvo and his colleagues27, which included all anti-MOG positive demyelinating diseases. This evidence concerns the gene AQP4 and demyelinating disease.